References
- Devalia V, Hamilton MS, Molloy AM. Guidelines for the diagnosis and treatment of cobalamin and folate disorders. Br J Haematol. 2014;166(4):496–513.
- Carmel R. Biomarkers of cobalamin (vitamin B-12) status in the epidemiologic setting: a critical overview of context, applications, and performance characteristics of cobalamin, methylmalonic acid, and holotranscobalamin II. Am J Clin Nutr. 2011;94(1):348s–58s.
- Lynch KL. Commentary. Clin Chem. 2017;63(6):1072–1073.
- Conjaerts SHP, Bruijnes JE, Beerhorst K, et al. [Nitrous oxide-induced polyneuropathy]. Ned Tijdschr Geneeskd. 2017;161:D2044.
- Garakani A, Jaffe RJ, Savla D, et al. Neurologic, psychiatric, and other medical manifestations of nitrous oxide abuse: a systematic review of the case literature. Am J Addict. 2016;25(5):358–369.
- Sluyts Y, Pals P, Amir R, et al. Recreational use of nitrous oxide may cause collateral neurological damage. Acta Neurol Belg. 2021;121(4):1097–1099.
- Blanco G, Peters HA. Myeloneuropathy and macrocytosis associated with nitrous oxide abuse. Arch Neurol. 1983;40(7):416–418.
- Duque MA, Kresak JL, Falchook A, et al. Nitrous oxide abuse and Vitamin B12 action in a 20-Year-Old woman: a case report. Lab Med. 2015;46(4):312–315.
- Thompson AG, Leite MI, Lunn MP, et al. Whippits, nitrous oxide and the dangers of legal highs. Pract Neurol. 2015;15(3):207–209.
- Edigin E, Ajiboye O, Nathani A. Nitrous oxide-induced B12 deficiency presenting with myeloneuropathy. Cureus. 2019;11(8):e5331.
- Hunt A, Harrington D, Robinson S. Vitamin B12 deficiency. BMJ (Clin Res Ed). 2014;349:g5226.
- Green R, Allen LH, Bjørke-Monsen AL, et al. Vitamin B(12) deficiency. Nat Rev Dis Primers. 2017;3:17040.
- Tjerk Wiersma HW-K. NHG-Standpunt Diagnostiek van vitamine-B12-deficiёntie. Huisarts Wetenschap 2014;57(9):472–475.
- Granados Sanchez AM, Posada G, Maria L, et al. Alejandra diagnostic approach to myelopathies. Rev Colomb Radiol. 2011;22(3):3231–3251.
- Asiri A, Dimpudus F, Atcheson N, et al. Comparison between 2D and 3D MEDIC for human cervical spinal cord MRI at 3T. J Med Radiat Sci. 2021;68(1):4–12.
- Vael L, Phyllis VW, Özsarlak Ö. MRI of nitrous oxide-related subacute cervical myelopathy. J Belg Soc Radiol. 2021;105(1):22.
- Yuan JL, Wang SK, Jiang T, et al. Nitrous oxide induced subacute combined degeneration with longitudinally extensive myelopathy with inverted V-sign on spinal MRI: a case report and literature review. BMC Neurol. 2017;17(1):222.
- Puri V, Chaudhry N, Goel S, et al. Vitamin B12 deficiency: a clinical and electrophysiological profile. Electromyogr Clin Neurophysiol. 2005;45(5):273–284.
- Gökçe Çokal B, Güneş HN, Güler SK, et al. Visual and somotosensory evoked potentials in asymptomatic patients with vitamin B12 deficiency. Eur Rev Med Pharmacol Sci. 2016;20(21):4525–4529.
- Pugliese RS, Slagle EJ, Oettinger GR, et al. Subacute combined degeneration of the spinal cord in a patient abusing nitrous oxide and self-medicating with cyanocobalamin. Am J Health-system Pharm. 2015;72(11):952–957.
- Huemer M, Diodato D, Schwahn B, et al. Guidelines for diagnosis and management of the cobalamin-related remethylation disorders cblC, cblD, cblE, cblF, cblG, cblJ and MTHFR deficiency. J Inherit Metab Dis. 2017;40(1):21–48.